By meeting challenges in caring for patients with chronic obstructive pulmonary dieases head-on, primary care doctors have an opportunity to reduce the potential for unnecessary or sub-optimal care while improving patient outcomes.
Almost 16 million Americans have chronic obstructive pulmonary disease (COPD).1 For many of these individuals, simple activities, such as walking or climbing stairs, leaves them breathless, making their lives a daily struggle.2 Primary care providers are the main point of contact for COPD patients, providing about 80% of their care.3 Most of the patients they treat present with symptomatic disease—the most common symptoms being shortness of breath, productive cough, fatigue, and limited exercise tolerance.4 Primary care providers’ main focus is to provide treatment to reduce patients’ symptoms and improve their quality of life.5,6
In treating COPD, it is important for primary care providers to grasp the complexity of the disease.7 No 2 COPD cases are alike; both the symptoms and the disease course vary by patient.7 Therefore, clinicians should tailor treatment to address individual patients’ symptoms, rather than managing all COPD patients the same. Clinicians also must recognize other key barriers to effective management of COPD. The following are some of the most common challenges in primary care: correctly identifying/diagnosing COPD; improving patient adherence to treatment; and reducing the risk of acute exacerbations. By meeting these challenges head-on, primary care doctors have an opportunity to reduce the potential for unnecessary or sub-optimal care while improving patient outcomes.8
Identifying and Diagnosing COPD
A major challenge facing primary care providers is diagnostic confusion between COPD and asthma.9 Both are complex, chronic conditions that cause obstructed airflow,9 and both share many of the same symptoms, such as shortness of breath and chronic cough.10 Spirometry testing is widely used in primary care to help clinicians diagnose either condition.4 However, a diagnosis based solely on spirometry may be erroneous, as partial reversibility of airflow obstruction with bronchodilator therapy is often seen in COPD and does not reliably distinguish between COPD and asthma.11 For a more accurate diagnosis, spirometry results should be combined with physical exam findings and a careful medical history that considers the patient’s age, onset and progression of symptoms and social and occupational risk factors. For example, some of the primary features of COPD include onset after age 40, persistent symptoms, and heavy exposure to risk factors, such as tobacco smoke or biomass fuels.4,11
Improving Patient Adherence and Treatment Outcomes
Inhaled bronchodilators are central to COPD treatment.12 It is becoming evident that certain patients may struggle to reach optimal peak inspiratory flow (PIF) with some inhalers.13 As a result, both the mode of delivery and the type of inhaler device are important considerations in COPD treatment.13 Device selection should be informed by the patient’s needs, preferences, and abilities.7,13 For instance, patients who find it hard to reach optimal PIF may benefit from an inhaler that requires less inspiratory effort to activate.14 Primary care practices should use multiple educational and training methods (eg, verbal, visual, demonstration) to instruct patients on proper inhaler technique. Instruction and review should be repeated at every office visit to ensure effective inhalation and drug delivery to optimize therapeutic outcomes.8,13
Reducing COPD Exacerbation Risk
Primary care providers’ main focus is to reduce their COPD patients’ symptom burden and associated comorbidities.4 Exacerbations — a sudden worsening, or flare-up, of symptoms7 — place a huge burden on some patients, as complications from these acute events can cause progressive airflow obstruction and lead to lengthy hospitalizations or even death.15 However, it is important to note that “frequent exacerbators” (ie, patients with 2 or more exacerbations requiring additional therapy and/or one hospitalization in the previous 12 months) are a small subset of COPD patients in primary care.9 In fact, the most severe and hard-to-treat COPD patients — ie, those who tend to experience frequent exacerbations and hospitalizations – mostly receive specialist care from pulmonologists.16
Nevertheless, primary care providers should assess their patients’ exacerbation status at every visit by monitoring the frequency with which patients require medical intervention for increased COPD symptoms. If a patient meets the criteria for frequent exacerbation, care providers should carefully assess both the patient’s adherence practices and the effectiveness of current therapy, and prescribe additional treatment or refer to specialist care as indicated.8
Best Practices in COPD Management
Ultimately, the treatment of COPD is a shared responsibility between the patient and the primary care provider — from the point of diagnosis and throughout the treatment journey. The following primary care best practices may facilitate a successful doctor-patient partnership and enhance COPD treatment outcomes:4
References:
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More